Business
Trying to fend off a hostile takeover attempt by Mylan’s $27 billion bid, Perrigo Chairman, President and CEO Joseph Papa sent a letter...
Hi, what are you looking for?
Jewish Business News
Business
The Israeli startup was founded in 2005 and raised $28 million to date.
Business
Mylan N.V. (NASDAQ: MYL) shareholders have approved Mylan’s proposed acquisition of Perrigo Company plc (NYSE: PRGO; TASE). The transaction received the approval of two-thirds of...
Business
Joseph Papa scathingly dismisses Mylan's latest tactic in lowering the stake it wants to buy in Perrigo. "today's announcement makes it even worse"
Business
Mylan could settle for buying control of Perrigo, rather than full ownership, keeping Perrigo listed on the TASE.
Business
The Israeli company develops bio-surgical medical devices for tissue repair.
Business
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) received the statistical analysis of results from a study which demonstrates that BiondVax’s universal flu vaccine...
Business
The acquisition gives Teva exclusive rights to Immuneering's cutting-edge analytics to advance treatments for diseases of the CNS.
Business
Teva CFO Eyal Desheh: We appreciate the strong support we received which stems from the compelling economics of this transaction
Business
Teva bought its 4.6% stake in Mylan at prices of $69-74 per share. the share price is down sharply in premarket trading.